4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-070147
Options or other derivatives
- Chief Scientific Officer acquired 42,210 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SMIDER VAUGHN · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-18 | Grant or award : show line 1 in the form Common Stock Option (right to buy) | +42,210 | 42,210 | D |
Loading xslF345X03/form471645_20141120045835-.xml…